BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 35275390)

  • 1. Neurological complications of COVID-19 in pediatric patients require comprehensive evaluation.
    Finsterer J
    J Neurovirol; 2022 Apr; 28(2):339-340. PubMed ID: 35275390
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurological complications of a SARS-CoV-2 infection require a thorough and comprehensive evaluation.
    Finsterer J
    Eur J Pediatr; 2024 Jun; 183(6):2811-2812. PubMed ID: 38492033
    [No Abstract]   [Full Text] [Related]  

  • 3. Are we sure that the neurological impact of COVID 19 in childhood has not been underestimated?
    Principi N; Esposito S
    Ital J Pediatr; 2021 Sep; 47(1):191. PubMed ID: 34537061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological infection with SARS-CoV-2 - the story so far.
    Solomon T
    Nat Rev Neurol; 2021 Feb; 17(2):65-66. PubMed ID: 33414554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological Complications of COVID-19 in Children.
    Ahmad S
    Pediatr Ann; 2021 Jun; 50(6):e259-e263. PubMed ID: 34115563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological complications in COVID-19 - a new diagnostic challenge.
    Vacaras V; Frunze S; Cordos MA
    J Med Life; 2022 Feb; 15(2):305-306. PubMed ID: 35419093
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to Clear-cut Definitions Is Mandatory When Assessing Short- and Long-term Neurological Complications of COVID-19.
    Finsterer J; A Scorza F
    Intern Med; 2022 Aug; 61(15):2399. PubMed ID: 35022351
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature.
    Siracusa L; Cascio A; Giordano S; Medaglia AA; Restivo GA; Pirrone I; Saia GF; Collura F; Colomba C
    Ital J Pediatr; 2021 Jun; 47(1):123. PubMed ID: 34078441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
    Chong ZZ; Souayah N
    Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does COVID-19 contribute to development of neurological disease?
    Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
    Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms.
    Neumann B; Schmidbauer ML; Dimitriadis K; Otto S; Knier B; Niesen WD; Hosp JA; Günther A; Lindemann S; Nagy G; Steinberg T; Linker RA; Hemmer B; Bösel J;
    J Neurol Sci; 2020 Nov; 418():117090. PubMed ID: 32805440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Review of COVID-19 Associated Neurological Manifestations.
    Aggarwal CS; Walser S; Bhandari A; Garg N; McClafferty B; Ramgobin D; Golamari R; Sahu N; Kumar A; Jain R
    S D Med; 2020 Dec; 73(12):569-571. PubMed ID: 33684975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SARS-CoV-2 and neurological disorders: the revelance of biomarkers?].
    Bigot-Corbel E; Lanore A; Raulet C; Delorme C; Azulay JP; Lehmann S; Beaudeux JL; Beauvieux MC; Sapin V; Peoc'h K; Rucheton B;
    Ann Biol Clin (Paris); 2021 Feb; 79(1):7-16. PubMed ID: 33570039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological complications in COVID-19 - a diagnostic challenge.
    Vacaras V; Frunze S; Cordos AM
    J Med Life; 2021; 14(2):216-224. PubMed ID: 34104245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The neurology of COVID-19].
    Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
    Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late neurological consequences of a SARS-CoV-2 infection].
    Michler E; Dolzhenko Y; Altmann C
    Dtsch Med Wochenschr; 2022 Feb; 147(4):173-177. PubMed ID: 35158380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.